We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Image of Sarah Whelan, PhD

Sarah Whelan, PhD profile page

Science Writer

Sarah joined Technology Networks in 2022 after completing a PhD in cancer biology, where her research focused on the development of colon cancers. In her role as science writer and editor, Sarah covers scientific news and a range of other content types, leading the site's coverage of drug discovery, biopharma and cancer research content.

Got a Question for Sarah Whelan, PhD?

Get in touch using the contact form linked here and we’ll get back to you shortly

Published Content
Total: 268
A person's hand with an IV.

Glowing Dye May Help Surgeons Cut Out Prostate Cancer

A fluorescent dye may provide surgeons with a “second pair of eyes” in surgery, helping to remove prostate cancer tumors without damaging healthy tissue.
A digital illustration of cells.

“Artificial Lymph Node” May Help Train the Immune System To Kill Cancer Cells

A new study has found that implanting an “artificial lymph node” under the skin of mice may act as a hub to teach immune cells how to recognize and kill cancer cells, prolonging mouse survival and slowing tumor growth.
Abstract psychedelic image of a person and clouds.

First Patient Dosed in Study To Unravel “Mystical Experiences” of Psychedelic Derived From Toad Skin

The first participant in a new psychedelic study has received a dose of a synthetic formulation of 5-MeO-DMT. The study is set to evaluate its neurophysiological effects on the human brain and perceived “mystical experiences.”
A digital illustration of a cell.

“Message in a Bottle” Cancer Therapy Shows Promise in Mice

Researchers have used small membrane bubbles – which our cells use to communicate – to deliver targeted cancer treatments to tumors in mouse models, demonstrating reduced tumor growth and extended survival in one model.
A bowl of white pills.

Metformin Use Linked to Reduced Blood Cancer Risk, Study Finds

A new study from Denmark has found that people taking the type 2 diabetes drug metformin are less likely to develop a myeloproliferative neoplasm (MPN) – a rare type of blood cancer that can develop into acute leukemia.
An image of a brain.

Protein Linked to Alzheimer’s May Shape Neuron Growth

A new study has described how a protein that helps to shape the growth of neurons – contactin-4 – also interacts with a protein involved in neurodevelopmental diseases and Alzheimer’s.
A scientist holding up a vial containing an image of a DNA double helix.

Top Trends Shaping Pharma in 2024: AI, Gene Editing, Biosimilars and Real-World Data

From AI's transformative role in drug discovery and CRISPR breakthroughs to the rise of biosimilars and real-world data. Learn how these innovations are reshaping pharma and driving progress in 2024.
Synthetic Biology in Medicine infographic snippet

Synthetic Biology in Medicine

Download this infographic to learn about medical applications for synthetic biology, such as diagnostics and biosensors, cell therapy and precision medicine, and synthetic bacterial therapeutics.
A vitamin D capsule.

Is Vitamin D Supplementation Really One-Size-Fits-All?

A new study suggests the need for personalized approaches to supplementation to help reduce vitamin D deficiency, which remains widespread despite extensive research.
An abstract image of a person with flowers growing from their head.

Researchers Uncover How Psychedelics Interact With Serotonin Receptors

Researchers have shed light on how some psychedelic drugs – which show promise in patients with neuropsychiatric disorders such as depression and anxiety – bind to and activate serotonin receptors.